Search Results - "Higuchi, Hisashi"

Refine Results
  1. 1

    Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms by Yoshida, Keizo, Takahashi, Hitoshi, Higuchi, Hisashi, Kamata, Mitsuhiro, Ito, Ken-ichi, Sato, Kazuhiro, Naito, Shingo, Shimizu, Tetsuo, Itoh, Kunihiko, Inoue, Kazuyuki, Suzuki, Toshio, Nemeroff, Charles B.

    Published in The American journal of psychiatry (01-09-2004)
    “…OBJECTIVE: With a multitude of antidepressants available, predictors of response to different classes of antidepressants are of considerable interest. The…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression by Higuchi, Hisashi, Takahashi, Hitoshi, Kamata, Mitsuhiro, Yoshida, Keizo

    Published in Neuropsychiatric disease and treatment (01-01-2009)
    “…The present study was conducted to find out the predictors of side effects such as nausea and excessive sweating induced by milnacipran, a…”
    Get full text
    Journal Article
  4. 4

    No Association of the G1287A Polymorphism in the Norepinephrine Transporter Gene and Susceptibility to Major Depressive Disorder in a Japanese Population by Inoue, Kazuyuki, Itoh, Kunihiko, Yoshida, Keizo, Higuchi, Hisashi, Kamata, Mitsuhiro, Takahashi, Hitoshi, Shimizu, Tetsuo, Suzuki, Toshio

    Published in Biological & pharmaceutical bulletin (01-10-2007)
    “…Norepinephrinergic neurotransmission in the central nervous system have a major impact on the symptomatology in major depressive disorder (MDD), and genetic…”
    Get full text
    Journal Article
  5. 5

    Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients by NAITO, SHINGO, SATO, KAZUHIRO, YOSHIDA, KEIZO, HIGUCHI, HISASHI, TAKAHASHI, HITOSHI, KAMATA, MITSUHIRO, ITO, KENICHI, OHKUBO, TADASHI, SHIMIZU, TETSUO

    Published in Psychiatry and clinical neurosciences (01-08-2007)
    “…Gender differences in the treatment response to fluvoxamine (selective serotonin re‐uptake inhibitor) and milnacipran (serotonin/norepinephrine re‐uptake…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Furunori (aged wheat starch paste): challenges of production in non-traditional settings by Belard, Regina, Higuchi, Hisashi, Perry, Jennifer

    Published in Journal of the Institute of Conservation (01-03-2009)
    “…Furunori (aged wheat starch paste) is a traditional adhesive used to bond layers of paper and/or silk in the mounting of Japanese scrolls. It differs from…”
    Get full text
    Journal Article
  10. 10

    Tardive dystonia and genetic polymorphisms of cytochrome P4502D6 and dopamine D2 and D3 receptors: A preliminary finding by Mihara, Kazuo, Kondo, Tsuyoshi, Higuchi, Hisashi, Takahashi, Hitoshi, Yoshida, Keizo, Shimizu, Tetsuo, Kaneko, Sunao

    Published in American journal of medical genetics (08-08-2002)
    “…Tardive dystonia is an uncommon but intractable and distressing complication of neuroleptic treatment. It is suggested that individual predisposing…”
    Get full text
    Journal Article
  11. 11

    Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients by Higuchi, Hisashi, Sato, Kazuhiro, Naito, Shingo, Yoshida, Keizo, Takahashi, Hitoshi, Kamata, Mitsuhiro, Yamaguchi, Noboru

    Published in Neuropsychiatric disease and treatment (01-01-2009)
    “…The effects of gender differences and age on the treatment response to fluvoxamine were investigated in major depressive Japanese patients. A total of 100…”
    Get full text
    Journal Article
  12. 12

    High-Performance Liquid Chromatographic Determination of Fluvoxamine and Fluvoxamino Acid in Human Plasma by OHKUBO, Tadashi, SHIMOYAMA, Ritsuko, OTANI, Koichi, YOSHIDA, Keizo, HIGUCHI, Hisashi, SHIMIZU, Tetsuo

    Published in Analytical Sciences (01-06-2003)
    “…A high-performance liquid chromatographic (HPLC) method has been developed for the simultaneous determination of fluvoxamine and its major metabolite…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: Two case reports by TAKAHASHI, Hitoshi, YOSHIDA, Keizo, HIGUCHI, Hisashi, SHIMIZU, Tetsuo, INOUE, Takeshi, KOYAMA, Tsukasa

    Published in Clinical neuropharmacology (01-09-2003)
    “…We illustrate 2 patients with depression who attained dramatic improvement of energy loss and fatigue when treated with cabergoline, a dopamine agonist, and…”
    Get full text
    Journal Article
  15. 15

    Milnacipran plasma levels and antidepressant response in Japanese major depressive patients by Higuchi, Hisashi, Yoshida, Keizo, Takahashi, Hitoshi, Naito, Shingo, Kamata, Mitsuhiro, Ito, Kenichi, Sato, Kazuhiro, Tsukamoto, Kei, Shimizu, Tetsuo, Nakanishi, Mamoru, Hishikawa, Yasuo

    Published in Human psychopharmacology (01-06-2003)
    “…The relationship between antidepressant effects and plasma levels of milnacipran was studied in 49 cases of major depression without psychotic features during…”
    Get full text
    Journal Article
  16. 16

    Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats by Yoshida, Keizo, Higuchi, Hisashi, Kamata, Mitsuhiro, Yoshimoto, Masaki, Shimizu, Tetsuo, Hishikawa, Yasuo

    “…1. 1. The effect of electroconvulsive shock (ECS) on the extracellular concentration of dopamine (DA), dihydroxyphenylacetic acid (DOPAC), homovanillic acid…”
    Get full text
    Journal Article
  17. 17

    Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment by Yoshida, Keizo, Higuchi, Hisashi, Kamata, Mitsuhiro, Yoshimoto, Masaki, Shimizu, Tetsuo, Hishikawa, Yasuo

    “…1. 1. The effect of electroconvulsive shock (ECS) on extracellular concentration of dopamine (DA), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA)…”
    Get full text
    Journal Article
  18. 18

    Panic attacks in patients with chronic schizophrenia: A complication of long‐term neuroleptic treatment by Higuchi, Hisashi, Kamata, Mitsuhiro, Yoshimoto, Masaki, Shimisu, Tetsuo, Hishikawa, Yasuo

    Published in Psychiatry and clinical neurosciences (01-02-1999)
    “…Panic attacks meeting the diagnostic criteria for panic disorder (DSM‐III‐R) were found in nine (20%) of 45 patients suffering chronic schizophrenia for more…”
    Get full text
    Journal Article
  19. 19

    Computational study on silicon oxide plasma enhanced chemical vapor deposition (PECVD) process using tetraethoxysilane/oxygen/argon/ helium by Li, Hu, Higuchi, Hisashi, Kawaguchi, Satoru, Satoh, Kohki, Denpoh, Kazuki

    Published in Japanese Journal of Applied Physics (01-06-2019)
    “…Plasma enhanced chemical vapor deposition (PECVD) of silicon oxide (SiO2) using tetraethoxysilane (TEOS) was investigated theoretically by developing an…”
    Get full text
    Journal Article
  20. 20

    No Association of the G1287A Polymorphism in the Norepinephrine Transporter Gene and Susceptibility to Major Depressive Disorder in a Japanese Population by Kazuyuki INOUEa, Kunihiko ITOHb, Keizo YOSHIDAc, Hisashi HIGUCHId, Mitsuhiro KAMATAe, Hitoshi TAKAHASHIf, Tetsuo SHIMIZUg, Toshio SUZUKIa

    “…Norepinephrinergic neurotransmission in the central nervous system have a major impact on the symptomatology in major depressive disorder (MDD), and genetic…”
    Get full text
    Journal Article